---
schema_version: "secwatch.filing_event.v1"
accession: "0001645113-26-000013"
form_type: "8-K"
ticker: "NVCR"
cik: "0001645113"
company_name: "NovoCure Ltd"
filed_at: "2026-02-24T23:59:59+00:00"
generated_at: "2026-05-16T00:49:15.580656+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# CMS rescinds retroactive revocation of Novocure's Medicare billing privileges

## Summary
- CMS revoked billing privileges retroactive to Dec 17, 2025; cited administrative re-validation issue, not substantive failure.
- On Feb 24, 2026, CMS rescinded revocation and reinstated privileges retroactively to Dec 17, 2025.
- Company continued patient services during revocation and expects no impact on revenue recognition.
- Revocation letter dated Jan 29, 2026; resolution achieved within one month.

## SEC filing metadata
- accession: 0001645113-26-000013
- form_type: 8-K
- ticker: NVCR
- cik: 0001645113
- company_name: NovoCure Ltd
- filed_at: 2026-02-24T23:59:59+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1645113/000164511326000013/0001645113-26-000013-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1645113/000164511326000013/nvcr-20260224.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001645113-26-000013
- JSON: https://secwatch.observer/filing/0001645113-26-000013.json
- Plain text: https://secwatch.observer/filing/0001645113-26-000013.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.